Do you want to read an article? Please log in or register.
Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study
Parkinson’s DiseaseAnxiety and Depression
Related content
Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial
JAMA Neurol.
Bond AE, Shah BB, Huss DS, Dallapiazza RF, Warren A, Harrison MB, Sperling SA, Wang XQ, Gwinn R, Witt J, Ro S, Elias WJ
doi: 10.1001/
Parkinson’s Disease
Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life
Neurology.
Sperling SA, Shah BB, Barrett MJ, Bond AE, Huss DS, Gonzalez Mejia JA, Elias WJ
doi: 10.1212/WNL.
Parkinson’s Disease
Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson's Disease
N Engl J Med
Martínez-Fernández R, Máñez-Miró JU, Rodríguez-Rojas R, Del Álamo M, Shah BB, Hernández-Fernández F, Pineda-Pardo JA, Monje MHG, Fernández-Rodríguez B, Sperling SA, Mata-Marín D, Guida P, Alonso-Frech F, Obeso I, Gasca-Salas C, Vela-Desojo L, Elias WJ, Obeso JA
doi: 10.1056/NEJMoa2016311
Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation
Lancet Neurol.
Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS
doi: 10.1016/
Predicting progression in patients with Parkinson's disease
Lancet Neurol.
Blauwendraat C, Bandrés-Ciga S, Singleton AB
doi: 10.1016/
Progression marker of Parkinson’s disease: a 4-year multi-site imaging study
Brain Neurology Journ.
Burciu RG, Ofori E, Archer DB, Wu SS, Pasternak O, McFarland NR, Okun MS, Vaillancourt DE
doi: 10.1093/brain/awx146.
Aging and Cognitive Functions
Correlation of Visuospatial Ability and EEG Slowing in Patients with Parkinson's Disease
Parkinsons Dis.
Eichelberger D, Calabrese P, Meyer A, Chaturvedi M, Hatz F, Fuhr P, Gschwandtner U
doi: 10.1155/2017/3659784.
RECOMMENDED
Parkinson’s Disease
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Lancet Neurol.
Olanow CW, Factor SA, Espay AJ, Hauser RA, Shill HA, Isaacson S, Pahwa R, Leinonen M, Bhargava P, Sciarappa K, Navia B, Blum D, CTH-300 Study investigators.
doi: 10.1016/S1474-4422(19)30396-5.
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
Lancet Neurol.
Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A
doi: 10.1016/S1474-